# Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm

> **NCT03478306** · PHASE3 · COMPLETED · sponsor: **Glostrup University Hospital, Copenhagen** · enrollment: 31 (actual)

## Conditions studied

- Diabetic Retinopathy
- Melatonin
- Circadian Dysrhythmia
- Circadian Rhythm Sleep Disorder, Unspecified Type

## Interventions

- **DRUG:** Melatonin 4 mg Tablet

## Key facts

- **NCT ID:** NCT03478306
- **Lead sponsor:** Glostrup University Hospital, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-27
- **Primary completion:** 2021-06-12
- **Final completion:** 2021-06-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03478306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03478306, "Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03478306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*